跳至主要内容
临床试验/NL-OMON46301
NL-OMON46301已完成不适用

Health effects of Sustainable future Proteins - Su-Pro studie

Wageningen Universiteit0 个研究点目标入组 36 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Age between 35-70y
  • -BMI between 18 - 30kg/m2

排除标准

  • - - Intake of medications known to change the inflammatory status (including proton pump inhibitors, anti-inflammatory medication (including NSAIDs)
  • - Having a history of medical or surgical events that may significantly affect the study outcome
  • - Kidney dysfunction (self-reported)
  • - Gastrointestinal disorders, constipation (defecation <3 times a week) or history of gastrointestinal surgery
  • - Allergies for our intervention products
  • - Recent use of antibiotics (<1 month prior to day 01 of the study)
  • - Not having a general practitioner
  • - Mental status that is incompatible with the proper conduct of the study
  • - Pregnancy or lactating
  • - Reported weight loss or weight gain of > 5 kg in the month prior to pre-study screening
  • - Reported slimming, medically prescribed, other (extreme) diet, or use of protein concentrates
  • - Not willing to give up blood donation during the study
  • - Current smokers
  • - Alcohol intake > 3 glasses per day
  • - Hard-drug abuse
  • - Participation in other clinical trials in the past month
  • - Being an employee (or student) of the department Consumer Science & Health group of Wageningen Food & Biobased Research
  • Additional exclusion for participation in the postprandial study:
  • - Having blood vessels that are too difficult for inserting a cannula
  • - Anaemia (Hb values <7.5 for women and < 8.5 for men)

研究者

相似试验